23andMe, Resigns
23andMe directors resign as the CEO of the genetic-testing company seeks to take it private
All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company. The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki,
Turmoil strikes 23andMe as board members resign in dispute with founder
Seven independent members of the company’s board resigned Tuesday, concluding that despite co-founder and CEO Anne Wojcicki’s expressed intention to take the company private, “no such proposal is forthcoming.
Genetic Testing Company 23andMe Settles Data Breach Lawsuit for $30 Million
Me will pay $30 million to settle a data breach lawsuit from the 2023 credential stuffing attack that exposed the personal and genetic information of 6.9 million customers.
23andMe board quits over plans to take DNA testing company private
All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan to take the company private. The departures leave just one sitting member of the board,
23andMe Board Resigns in New Blow to DNA-Testing Company
All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne Wojcicki over her plan to take the company private.
23andMe independent directors quit board over unsatisfactory buyout plan from CEO
The independent directors of genetic testing firm 23andMe said on Tuesday they have resigned from the company's board after not receiving a satisfactory take-private offer from CEO Anne Wojcicki.
23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
What happened to 23andMe?
The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...
How 23andMe Went From Market Darling to Losing Its Entire Board
The biotech company 23andMe has a big mess to clean up after its entire board resigned to protest its CEO’s plans to take the ...
CNET on MSN1d
23andMe Agrees to $30M Settlement That Could Pay $10,000 to Data Breach Victims
Personal information for nearly half of the popular genetic testing company's customers -- 6.9 million people -- were exposed ...
JD Supra20h
23andMe’s $30M Settlement: What It Means for Companies Handling Genetic and Genomic Data
The recent $30 million settlement between 23andMe and 6.4 million users following a major data breach offers important lessons for businesses ...
MedPage Today on MSN23h
RFK Jr. Helping Trump Pick CDC Chief; Excess COVID Death Lingers; Turmoil at 23andMe
The House passed 14 bipartisan health bills. Here's a rundown on the legislation from the office of Rep. Cathy McMorris ...
Read the memo 23andMe's cofounder sent to staff after the entire board quit
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.